BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1403117)

  • 1. Is vasospasm related to proliferative arteriopathy?
    Pluta RM; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
    J Neurosurg; 1992 Nov; 77(5):740-8. PubMed ID: 1403117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
    Hara H; Nosko M; Weir B
    J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cerebral vasospasm following subarachnoid hemorrhage in monkeys.
    Macdonald RL; Weir BK; Grace MG; Chen MH; Martin TP; Young JD
    Can J Neurol Sci; 1992 Nov; 19(4):419-27. PubMed ID: 1423039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys.
    Macdonald RL; Weir BK; Young JD; Grace MG
    J Neurosurg; 1992 Jan; 76(1):81-90. PubMed ID: 1727173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
    Pluta RM; Oldfield EH; Boock RJ
    J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y in the primate model of subarachnoid hemorrhage.
    Pluta RM; Deka-Starosta A; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
    J Neurosurg; 1992 Sep; 77(3):417-23. PubMed ID: 1506889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage.
    Afshar JK; Pluta RM; Boock RJ; Thompson BG; Oldfield EH
    J Neurosurg; 1995 Jul; 83(1):118-22. PubMed ID: 7782826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage.
    Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH
    J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
    Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
    Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage.
    Pluta RM; Afshar JK; Boock RJ; Oldfield EH
    J Neurosurg; 1998 Mar; 88(3):557-61. PubMed ID: 9488312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage.
    Nakao K; Murata H; Kanamaru K; Waga S
    Stroke; 1996 Oct; 27(10):1882-7; discussion 1887-8. PubMed ID: 8841348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model.
    Handa Y; Kabuto M; Kobayashi H; Kawano H; Takeuchi H; Hayashi M
    Neurosurgery; 1991 Apr; 28(4):542-9. PubMed ID: 2034349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology of cerebral vasospasm in primates.
    Macdonald RL; Weir BK; Runzer TD; Grace MG; Findlay JM; Saito K; Cook DA; Mielke BW; Kanamaru K
    J Neurosurg; 1991 Sep; 75(3):415-24. PubMed ID: 1869943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical manipulation of primate cerebral arteries in established vasospasm.
    Findlay JM; Macdonald RL; Weir BK; Grace MG
    J Neurosurg; 1991 Sep; 75(3):425-32. PubMed ID: 1869944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm.
    Pluta RM; Thompson BG; Dawson TM; Snyder SH; Boock RJ; Oldfield EH
    J Neurosurg; 1996 Apr; 84(4):648-54. PubMed ID: 8613858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage.
    Horky LL; Pluta RM; Boock RJ; Oldfield EH
    J Neurosurg; 1998 Feb; 88(2):298-303. PubMed ID: 9452239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage.
    Kanamaru K; Weir BK; Findlay JM; Krueger CA; Cook DA
    J Neurosurg; 1989 Dec; 71(6):909-15. PubMed ID: 2511283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of timing of clot removal on chronic vasospasm in a primate model.
    Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
    J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in a primate model of cerebral vasospasm.
    Iuliano BA; Pluta RM; Jung C; Oldfield EH
    J Neurosurg; 2004 Feb; 100(2):287-94. PubMed ID: 15086237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.